Members |
targetComponentId |
Child specific referral NOS |
Referral of child |
Undersøgelse af barn i pleje, ikke nærmere specificeret |
Child into care medical examination |
Child to care exam NOS |
Child into care medical examination |
Child weight centiles NOS |
Child weight centiles - finding |
vægtpercentiler for børn, ikke nærmere specificeret |
Child weight centile |
Child: agency involved NOS |
Child agency involvement status |
Child: agency involved NOS |
Child agency involvement status |
epilepsi i barndommen med occipitale paroksysmer |
Occipital lobe epilepsy |
infantilt anfald |
Seizure |
Chilognatha |
Class Diplopoda (organism) |
kinesisk restaurant-syndrom |
Monosodium glutamate symptom complex comprises of a set of symptoms with onset after ingestion of monosodium glutamate. The symptoms include migraine headache, urticaria, angioedema or rhinitis. |
Chlamydia pneumoniae deoxyribonucleic acid |
Chlamydophila pneumoniae DNA |
chloralhydrat 250 mg/5 ml syrup |
Chloral hydrate 50 mg/mL oral solution |
chloralhydrat suppositorier 10 g |
Chloral hydrate 650 mg rectal suppository |
chloralhydrat suppositorier 5 g |
Chloral hydrate 325 mg rectal suppository |
chloralsedativum |
Chloral derivative (substance) |
chloramin-T-specifikt ekstrakt |
Product containing tosylchloramide sodium (medicinal product) |
chloramphenicol (antibiotikagruppe) |
Chloramphenicol (substance) |
Chloramphenicol 0,25 % øjendråber |
Chloramphenicol (as chloramphenicol sodium succinate) 2.5 mg/mL eye solution |
Chlorhexidine |
Product containing chlorhexidine (medicinal product) |
Chlorhexidine digluconate+amethocaine 0.05/0.015% oral spray |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
chlorhexidingluconat 0,02 % i 70 % IMS, spray |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
Chlorhexidine gluconate 0.02% in 70% IMS spray refill |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
chlorhexidingluconat 0,5 % i 70 % IMS, opløsning |
Chlorhexidine gluconate 50 mg/mL cutaneous solution |
chlorhexidingluconat 0,5 % i 70 % IMS, spray |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Chlorhexidine gluconate 0.5% in 70% IMS spray refill |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
chlorhexidingluconat 2 % + isopropylalkohol 70 % svamp til topikal anvendelse |
Product containing only chlorhexidine and isopropyl alcohol (medicinal product) |
chlorhexidingluconat 3,15 %/isopropylalkohol 70 % vatpind til topikal anvendelse |
Product containing only chlorhexidine and isopropyl alcohol (medicinal product) |
chlorhexidingluconat 1 % + ethylalkohol 61 % opløsning |
Product containing only chlorhexidine and ethanol (medicinal product) |
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% conventional release oromucosal spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
chlorhexidingluconat 0,2 % + lidocainhydrochlorid 0,05 % halsspray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
Chlorhexidine gluconate+lignocaine hydrochloride 0.2%/0.05% throat spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
chlorhexidingluconat + natriumnitrit 0,5 %/0,1 % i 70 % IMS, opløsning |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Chlorhexidine hydrochloride+neomycin sulfate |
Product containing chlorhexidine and neomycin (medicinal product) |
bivirkning af chloreret phenol-desinfektionsmiddel |
Chlorinated phenol adverse reaction |
allergi over for chloreret phenol-desinfektionsmiddel |
Allergy to chlorinated phenol (finding) |
forgiftning med chlorbenzoesyre |
Poisoning by 4-chlorobenzoic acid |
ikke-farmaceutisk misbrugsstof i form af kloroform |
Chloroform |
Chlorophenothane |
Clofenotane |
chloroprocainhydrochlorid 1 % injektionsvæske, opløsning, ampul |
Product containing only chloroprocaine (medicinal product) |
chloroprocainhydrochlorid 2 % injektionsvæske, opløsning, ampul |
Product containing only chloroprocaine (medicinal product) |
chloroprocainhydrochlorid 3 % injektionsvæske, opløsning, ampul |
Product containing only chloroprocaine (medicinal product) |
Chloroxylenol |
Chloroxylenol (substance) |
chlorpheniramin 2 mg + ibuprofen 200 mg + pseudoephedrin 30 mg tablet |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
Chlorpheniramine 2mg/ibuprofen 200mg/pseudoephedrine 30mg conventional release oral tablet |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
Chlorpheniramine maleate |
Product containing chlorphenamine (medicinal product) |
chlorpheniraminmaleat 8 mg + methscopolaminnitrat 2,5 mg + pseudoephedrinhydrochlorid 120 mg tablet med modificeret udløsning |
Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet |
Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
Chlorpheniramine maleate + pseudoephedrine hydrochloride |
Product containing chlorphenamine and pseudoephedrine (medicinal product) |
chlorpheniraminmaleat 4 mg + phenylephrinhydrochlorid 20 mg + phenyltoloxamincitrat 50 mg kapsel med modificeret udløsning |
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form |
Chlorpheniramine maleate+phenylephrine hydrochloride+phenyltoloxamine citrate 4mg/20mg/50mg prolonged-release oral capsule |
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form |
chlorpromazinhydrochlorid 10 mg/5 ml syrup |
Chlorpromazine hydrochloride 2 mg/mL oral solution |
chlorpromazinhydrochlorid kapsel med modificeret udløsning a 150 mg |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorpromazine hydrochloride 150mg prolonged-release oral capsule |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
chlorpromazinhydrochlorid kapsel med modificeret udløsning a 30 mg |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorpromazine hydrochloride 30mg prolonged-release oral capsule |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
chlorpromazinhydrochlorid 50 mg/5 ml syrup |
Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
chlorpromazinhydrochlorid kapsel med modificeret udløsning a 75 mg |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorpromazine hydrochloride 75mg prolonged-release oral capsule |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
Chlorprothixene overdose |
Chlorprothixene overdose (disorder) |
chlortetracyclinhydrochlorid 3 % salve |
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
normalt fund ved kolangiografi |
Fluoroscopic cholangiography with contrast normal |
normalt fund ved kolangiografi efter kolecystektomi |
Postoperative fluoroscopic cholangiography with contrast normal |
normalt kolangiogram efter sfinkterotomi |
Postoperative fluoroscopic cholangiography with contrast normal |
kolecystektomi og operativ kolangiografi |
Cholecystectomy with intraoperative fluoroscopic cholangiography with contrast (procedure) |
kolecystektomi med eksploration af ductus choledochus med kolangiografi |
Cholecystectomy and exploration of common bile duct with intraoperative fluoroscopic cholangiography with contrast (procedure) |
kolecystokolangiografi |
Percutaneous transhepatic fluoroscopic cholecystocholangiography with contrast |
Choledochotomy - obstruction NOS |
Incision of common bile duct |
Koledokotomi obstruktion, ikke nærmere specificeret |
Incision of common bile duct |
Cholelitiasis, ikke nærmere specificeret |
Biliary calculus |
Cholelithiasis NOS |
Biliary calculus |
Cholera vaccination NOS |
Administration of cholera vaccine |
koleravaccination, ikke nærmere specificeret |
Administration of cholera vaccine |
Kolesteatom med komplikationer |
Cholesteatoma |
cholesterolanalyt |
Cholesterol |
kolesteroleduktionsprogram, afvist |
Cholesterol reduction programme declined |
colestyramin + sucrose |
Product containing colestyramine (medicinal product) |
cholestyramin 4 g pulver |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine 4g suspension |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine 4g/unit powder |
Colestyramine 4 g powder for oral suspension sachet |
Cholestyramine 4g/unt powder |
Colestyramine 4 g powder for oral suspension sachet |
kolestyramin + aspartam |
Product containing colestyramine (medicinal product) |
cholestyramin + aspartam 4g/brev pulver |
Colestyramine 4 g powder for oral suspension sachet |
Choline salicylate 870mg/5ml liquid |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) |
cholinsalicylat 20 % + glycerol 12,6 % øredråber |
Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) |
allergi over for cholintheophyllinat |
Allergy to theophylline (finding) |
Kondrokalcinose forårsaget af dicalciumfosfatkrystaller, ikke nærmere specificeret |
Chondrocalcinosis caused by dicalcium phosphate crystals |
Kondrokalcinose forårsaget af dicalciumfosfatkrystaller med anden specificeret lokalisation |
Chondrocalcinosis caused by dicalcium phosphate crystals |
Kondrokalcinose forårsaget af dicalciumfosfatkrystaller uden specificeret lokalisation |
Chondrocalcinosis caused by dicalcium phosphate crystals |
Chondrocyte cell |
Chondrocyte (substance) |
kondrosarkom iht. kategori |
Chondrosarcoma |
kondrosarkom, ingen IDC-O-undertype |
Chondrosarcoma |
koriokarcinom |
Choriocarcinoma (morphologic abnormality) |
choriogonadotropin alfa 10.000 IE pulver og solvens til injektionsvæske, opløsning, ampul |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 10,000iu powder for conventional release solution for injection ampule |
Choriogonadotropin alfa only product in parenteral dose form |
choriogonadotropin alfa 1500 IE pulver og solvens til injektionsvæske, opløsning, ampul |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 1500iu powder for conventional release solution for injection ampule |
Choriogonadotropin alfa only product in parenteral dose form |
choriogonadotropin alfa 2000 IE pulver og solvens til injektionsvæske, opløsning, ampul |
Choriogonadotropin alfa only product in parenteral dose form |
Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule |
Choriogonadotropin alfa only product in parenteral dose form |
choriogonadotropin alfa 5000 IE pulver og solvens til injektionsvæske, opløsning, ampul |
Product containing only choriogonadotropin (medicinal product) |